⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taurine SCHEMBL28030417 | 0.97 | — | — | |
| Taurine SCHEMBL6363956 | 0.97 | BLM (0.88) | — | |
| Taurine SCHEMBL42632 | 0.97 | BLM (1.00) | — | |
| Taurine SCHEMBL30179154 | 0.97 | — | — | |
| Taurine SCHEMBL23068 | 0.97 | — | — | |
| Taurine SCHEMBL30191395 | 0.97 | — | — | |
| Taurine SCHEMBL3667691 | 0.93 | — | — | |
| Taurine SCHEMBL19438470 | 0.93 | — | — | |
| Taurine SCHEMBL8052521 | 0.93 | BLM (0.93) | — | |
| Taurine SCHEMBL923628 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120283961-B | Vitamin premix and preparation process thereof | 江苏紫东食品有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-115708457-B | Propagation and cultivation method of azalea | 陕西省西安植物园(陕西省植物研究所) | 2025-02-18 | — | — | CN | claimed |
| CN-118716256-B | In-situ treatment method for net cage culture substrate by combining bacterial colony with urechis unicinctus | 山东省海洋资源与环境研究院(山东省海洋环境监测中心、山东省水产品质量检验中心) | 2025-01-14 | — | — | CN | claimed |
| CN-118716256-A | In-situ treatment method for net cage culture substrate by combining bacterial colony with urechis unicinctus | 山东省海洋资源与环境研究院(山东省海洋环境监测中心、山东省水产品质量检验中心) | 2024-10-01 | — | — | CN | claimed |
| CN-117126083-A | Preparation process of magnesium taurine salt and magnesium taurine complex | 刘桂姣 | 2023-11-28 | — | — | CN | claimed |
| US-11433043-B2 | Compounds useful for increasing neurogenesis in neural tissue | ALFASIGMA S.P.A. (IT) | 2022-09-06 | — | — | US | claimed |
| CN-113925866-A | Use of kinase inhibitor in preparation of male contraceptive medicine or product | 华中科技大学 | 2022-01-14 | — | — | CN | claimed |
| CN-111960972-A | Preparation process and application of taurine magnesium salt and taurine magnesium complex | 许昌远志生物科技有限公司 | 2020-11-20 | — | — | CN | claimed |
| US-20200323809-A1 | COMPOUNDS USEFUL FOR INCREASING NEUROGENESIS IN NEURAL TISSUE | ALFASIGMA S.P.A. (IT) | 2020-10-15 | — | — | US | claimed |
| EP-2124925-B1 | COMPOSITION USEFUL FOR THE TREATMENT OF TYPE 2 DIABETES | ALFASIGMA SPA (IT) | 2018-06-27 | — | — | EP | claimed |
| US-20040142879-A1 | Use of the acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus | CALVANI MENOTTI (IT) | 2004-07-22 | — | — | US | claimed |
| US-20040077718-A1 | Use of isovaleryl l-carnitine for the preparation of a medicament for the prevention and cure of osteoporosis | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2004-04-22 | — | — | US | claimed |
| EP-1399143-A1 | USE OF AN ALKANOYL L-CARNITINE FOR THE PREPARATION OF A MEDICATION TO TREAT ANHEDONIA | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2004-03-24 | — | — | EP | claimed |
| EP-1399141-A1 | USE OF ACETYL L-CARNITINE FOR THE PREPARATION OF A MEDICATION FOR THE PREVENTIVE THERAPY FOR PAIN | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2004-03-24 | — | — | EP | claimed |
| EP-1399142-A1 | USE OF ACETYL L-CARNITINE IN ASSOCIATION WITH THE BIOTIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 INSULIN-RESISTANT DIABETES MELLITUS | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2004-03-24 | — | — | EP | claimed |
| EP-1351676-A1 | USE OF ISOVALERYL L-CARNITINE FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND CURE OF OSTEOPOROSIS | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2003-10-15 | — | — | EP | claimed |
| WO-2002096411-A1 | USE OF AN ALKANOYL L-CARNITINE FOR THE PREPARATION OF A MEDICATION TO TREAT ANHEDONIA | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-12-05 | — | — | WO | claimed |
| WO-2002096409-A1 | USE OF ACETYL L-CARNITINE FOR THE PREPARATION OF A MEDICATION FOR THE PREVENTIVE THERAPY FOR PAIN | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-12-05 | — | — | WO | claimed |
| WO-2002096410-A1 | USE OF THE ACETYL L-CARNITINE IN ASSOCIATION WITH THE BIOTIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 INSULIN-RESISTANT DIABETES MELLITUS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-12-05 | — | — | WO | claimed |
| WO-2002049639-A1 | USE OF ISOVALERYL L-CARNITINE FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND CURE OF OSTEOPOROSIS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2002-06-27 | — | — | WO | claimed |